Abstract Background
The goal of this study is to understand role of transforming growth factor beta 1 (TGF--β1) in development of osteoarthritis (OA). Results from studies indicate that the genetic inactivation of Smad--3, or the disruption of the interaction of Tgf--β1 with its receptor Tgf--β type II receptor (Tgfbr2), in germline cells results in OA--like knee joints in mice at one month of age. However, other studies suggest that the increased expression of Tgf--β1 in mature knee joints causes OA in animal models. A human genetic study reports that a two--nucleotide deletion, 741--742del AT, and/or a nucleotide change, 859C>T or 782C>T in SMAD--3 are associated with early--onset OA. This observation is consistent with the finding that the lack of Tgf--β1 signaling in the germline cell results in OA in developing joints and that increased Tgf--β1 signaling causes OA in mature joints. The plausible explanation for this "conflicting" role of TGF--β1 in the pathogenesis of OA is that the effective TGF--β1 signaling acts in either a dose-dependent or a developmental stage--dependent manner. The present study addresses the question as to whether inhibition of Tgf--β1 signaling prevents mature knee joints from being degenerated in mouse models of OA. Methods 1) Using conditional knock out techniques with aggrecan--CreERt2 mice and floxed Tgfbr2 mice, Tgfbr2 was removed from articular cartilage of knee joints in 2--month--old mice. Mice without Tgfbr2 were kept for another 6 months or longer. Knee joints from the mice (n=8) and their corresponding control (n=4) were collected for morphological analysis.
2) Mice without Tgfbr2 at two months old were subjected to DMM to induce articular cartilage degeneration. Knee joints from the mice at 4 and 8 weeks post surgery (n=8 in each group) were collected for morphological analysis.
Results

1)
We did not find the initiation and acceleration of articular cartilage degeneration by the genetic inactivation of Tgfbr2 in knee joints of mice at the age of 9 months or older. We also did not find hypertrophic chondrocytes in the articular cartilage of the mice.
2) We found that removal of Tgfbr2 in articular cartilage of knee joints delayed articular cartilage degeneration, at least 6 weeks, compared to that in wild--type littermates.
Conclusion
Inhibition of Tgf--β1 signaling attenuated articular cartilage degeneration in mature knee joints of mouse models of OA. Therefore, inhibition activity of TGF--β1, not application of TGF--β1, may be considered in treatment of OA in mature joints.
Introduction
Osteoarthritis (OA) is a progressive synovial joints disease, caused by the imbalance between the anabolic and catabolic activities of the articular chondrocytes and consequently leads to the degradation of the cartilage and failure in repairing of the damaged joint damage. proposing a causal sequence of the molecular events that contributes the articular cartilage degeneration (3--6) .
Role of MMP13 in the pathogenesis of OA:
Expression of MMP13 is hardly detected in normal mature articular cartilages, but the activity and expression of the enzyme are increased in human OA cartilages and in mouse models of OA. MMP--13 is believed to play an important role in OA because of its ability of degrading both aggrecans and collagen type II (7, 8) . The constitutive expression of Mmp--13 in mouse cartilage results in OA--like changes to the knee joints (9) and removal of this enzyme prevents articular cartilage erosion in a joint instability mouse model of OA (10) . Results from another study demonstrated that articular cartilage degradation is completely irreversible after induction of MMP--mediated degradations of aggrecan and collagen type II (11) . If the degradation of collagen type II is irreversible, then, in order to intervene in the progression of OA, the inhibition of the MMP--13 activity and expression becomes crucial. Results from our recent studies suggest that DDR2 may be a "stimulant" in chondrocytes.
Role of DDR2 in the induction of MMP13 in chondrocytes: Synthesis of chondrocytes
and releasing of matrix--degrading enzymes can be incited by altered mechanical forces, and consequently lead to the degradation of the pericellular matrix of chondrocytes, and enhances the exposure of the chondrocytes to native collagen type II. Interaction of the chondrocytes with native collagen type II fibrils results in up--regulated activity and expression of DDR2 and induction of MMP--13. MMP--13 functions as cleaving collagen type II and aggrecans (7, 8) . The resulting fragments of collagen type II and aggrecans may further increase the synthesis of MMP--13 through interaction with other cell-surface receptors (12) . This result is a positive feedback amplification loop that leads to the irreversible destruction of the articular cartilage. Experiments found that 1) reduced expression of DDR2 attenuated articular cartilage degeneration in the mouse models of OA; 2) the levels of MMP--13 and DDR2 mRNAs were elevated in human chondrocytes and mouse primary chondrocytes cultured on native collagen type II, indicating that native collagen type II induces expression of DDR2 and MMP--13 mRNAs;
and 3) When human chondrocytes were cultured on denatured collagen type II (gelatin), the levels of MMP--13 and DDR2 mRNAs were not elevated, suggesting that the chondrocytes respond in a specific manner to triple--helical collagen type II. Based on these results, we concluded that the activation of DDR2, through the interaction of the receptor with collagen type II, increases the expression of MMP--13 in chondrocytes, resulting in the destruction of articular cartilage (13--18) .
Role of the high temperature requirement A1 (HTRA1) the pathogenesis of OA:
Chondrons are composed of chondrocytes, a pericellular matrix, and a capsule surrounding the pericellular matrix. The pericellular matrix separates chondrocytes from the adjacent interterritorial or territorial matrices containing collagen type II, and also prevents newly synthesized collagen type II from binding to DDR2 during the developmental stage or in mature articular cartilage. Results from human and mouse genetic studies indicate that maintaining the integrity of the pericellular matrix is one of the key elements in protecting against OA. The pericellular matrix of chondrocytes is disrupted in human OA cartilages. It is obvious that enzymes that are capable of degrading the pericellular molecules will play an important role in the pathogenesis of OA, and HTRA1 may be one such enzyme (19, 20) . The expression of HTRA1 is predominantly increased in human OA cartilages and in the articular cartilages of joints from animal models of OA. More importantly, HTRA1 can degrade the pericellular components such as decorin, biglycan, COMP, fibronectin, and aggrecan. It is also found that pericellular collagen type VI was not present in chondrocytes expressing HTRA1 in mouse OA joints, which is indicative of the disruption of the pericellular matrix of chondrocytes. Also, those cells without surrounding collagen type VI were associated with an increased expression of Ddr2, which suggests that HTRA1 may contribute to the development of OA through the degradation of the pericellular network, resulting in activation of DDR2 (21, 22) .
Role of transforming growth factor beta 1 (TGF--β1) in the pathogenesis of OA: TGF--
b1 has been considered an anabolic factor to articular chondrocytes, based largely on results from in vitro and ex vivo experiments in which TGF--β1 can stimulate chondrocytes to synthesize and release extracellular matrix molecules, including proteoglycans and type II collagens (23, 24) . In addition, results from two studies indicate that the genetic inactivation of Smad--3 or disruption of the interaction of Tgf--β1 with its receptor, Tgf--β type II receptor (Tgfbr2), in germline cells causes OA--like knee joints in mice (25, 26) .
Moreover, a human genetic study reports that a two--nucleotide deletion, 741--742del AT (nonsense mutation), in SMAD--3 causes early--onset OA in a human family (27) . This is consistent with the results from the animal models, indicating that the lack of Tgf--β1 signaling in the germline cell results in OA. However, observations from other studies also suggest that the increased TGF--β1 signaling may initiate and accelerate articular cartilage degeneration in mature joints.
First, the enhanced production of extracellular matrix molecules, due to an increase in the synthetic activity of chondrocytes, is not necessarily beneficial or physiological in maintenance of the homeostasis of mature articular cartilage. For instance, one of the earliest pathological signs in articular cartilage degeneration is the overproduction of proteoglycans in mouse models of OA (5, 6) . A study by Van den Berg et. al. reports that the constitutive overexpression of active TGF--β1 in adult mouse knee joints results in OA associated with increase in the production of proteoglycans in articular cartilage, hyperplasia of synovium and chondro--osteophyte formation (28) . Thus, the overproduction of proteoglycans in articular cartilage could be a pathologic response of the chondrocyte in the early stages of articular cartilage degeneration. This raises an interesting question: does TGF--β1 disrupt homeostasis of articular cartilage instead of repairing the damaged cartilage in mature joints? Second, the human genetic study reports that a nucleotide change, 859C>T or 782C>T in SMAD--3, increases the level of TGF--β1 and activity of the TGF--β1 signaling pathway in two human families associated with early--onset OA (27) . This is in agreement with the observation from two other studies indicating that the level of TGF--β1 is significantly higher in human osteoarthritic tissues than in healthy articular cartilages (29, 30) . Studies with animal models, by 
Hypothesis
The deficiency of TGF--β1 may have chondroprotective effect on articular cartilage degeneration in mature joints. 
Specific Aim
Materials and Methods
The 
Evaluation of articular cartilage conditions by a scoring system. The pathologic condition
of the joints was evaluated by a scoring system designed to assess the histology of OA in mouse joints; the system is recommended by the OARSI histopathology initiative (11) . The score 0 is for normal mouse articular cartilage; 0.5 for Loss of Safranin--O without structural changes; 1 for small fibrillations without loss of cartilage; 2 for vertical clefts down to the layer immediately below the superficial layer and some loss of surface lamina; 3 for vertical clefts/erosion to the calcified cartilage extending to <25% of the articular surface; 4 for vertical clefts/erosion to the calcified cartilage extending to 25 to 50% of the articular surface; 5 for vertical clefts/erosion to the calcified cartilage extending to 50 to 75% of the articular surface; and 6, the maximal score, for vertical clefts/erosion to the calcified cartilage extending >75% of the articular surface.
Statistic analysis. There were 9 to 10 paraffin sections from each knee joint. The score from the section of the worst condition was selected to represent the joint. Thus, six to eight scores were obtained for each experimental group. An average score for each experimental group was then calculated from the scores.
The t--test with a significance level of 0.05 was used to determine whether a significant difference between any two average scores was present. With regard to the determination of sample size in this study, a pilot study and power analysis on the effect of the Tgfbr2--deficiency was performed. From the results, it was concluded that a sample size 6 is required to achieve the specified confidence interval with at least 50% reduction of the score in the treatment group and with a 95% confidence level. 
Immunohistostaining for p--
Results
No morphological effect of a genetic inactivation of Tgfbr2 in the articular cartilage of adult mouse joints.
First, we used a specific mouse strain, Cre--recombinase and the modified estrogen receptor (CreERT2) driven by the aggrecan promoter, Agc1 tm (IRES--CreERT2) . The result from a previous study demonstrates that CreERT2 is highly inducible in the articular chondrocytes of adult knee joints in Agc1 tm (IRES--CreERT2) mice (16) . In our experiment, we examined the efficiency of the ablation of analysis. We found that there was no morphological differences between AgcCreERT2 +/--;Tgfbr2 +/+ and the wild--type littermates, indicating no morphological effect by the insertion of the CreERT2 in the mouse genome. This is consistent with the observation by another independent investigation (16) . We also did not found the morphological differences between AgcCreERT2 +/--;Tgfbr2 f/f and AgcCreERT2 +/--;Tgfbr2 +/+ mice, figure 2. This indicated that the removal of Tgfbr2 from the articular cartilage did not cause any morphological changes in knee joints of mice after mature (adult mice).
Third, data from in vivo experiments indicate that inhibition activity of TGF--β1 signaling results in the pre--mature hypertrophy of articular chondrocytes in mouse joints during early development (before mouse mature at the age of 6 to 8 weeks). Type X collagen is one of the markers for chondrocyte hypertrophy. We examined the protein expression of type X collagen in the articular cartilage of knee joints of mice at 12 months old. In these mice, Tgfbr2 had been removed from the articular cartilages at the age of 2 months. The mice continued to live for 10 more months. However, we did not detect the protein expression of type X collagen in the articular cartilage of knee joints in these mice, figure 3 .
Forth, although a previous study reports that the expression of CreERT2 is inducible in the articular chondrocyte of adult knee joints in Agc1 tm (IRES--CreERT2) mice, it is unknown whether CreERt2 is also inducible in the articular cartilage of adult temporomandibular (TM) joints. By crossing Agc1 tm (IRES--CreERT2) mice with Rosa--26 reporter mice, we found that CreERT2 was highly expressed in the articular cartilage of TM joints in mice at the age of 6 months old, figure  4 . This result indicated that Agc1 tm (IRES--CreERT2) mouse strain could also be used to remove a gene of interest in the articular cartilage of adult TM joints.
Fifth, we examined morphology of TM joints from AgcCreERT2 +/--;Tgfbr2 +/+ , AgcCreERT2 +/--;Tgfbr2 f/f mice and their wild--type littermates at the ages of 6 and 12 months old. We found that there were no morphological differences in TM joints among the mice, figure 5 . This result was consistent with our observation in adult knee joints, in which the removal of Tgfbr2 from the adult articular cartilage did not cause any overt morphological changes in the joints. cartilages. This also suggests that it may not be needed for chondrocytes to continually produce type II collagen in mature articular cartilage. Thus, the TGF--β1--stimulated overproduction of type II collagen or/and proteoglycans in mature articular cartilage, in fact, may disrupt the homeostasis of the cartilage, which eventually leads to cartilage degeneration. Second, an independent research group finds that TGF--β1 induces a serine protease, high temperature requirement A1 (HTRA1) in human chondrocytes (34) . Results from our in vitro experiments confirmed this observation (33). Furthermore, we found increases in the expression of Tgf--β1, p--Smad2/3 and HtrA1 in articular chondrocytes of knee joints in mouse models of OA and increased expressions of p--Smad2/3 and HtrA1 were co--localized in the chondrocyte. In addition, TGF--β1--induced expression of HTRA1 was inhibited by an ALK--5 inhibitor, SB431542, in human and mouse chondrocytes. This suggests that Tgf--β1 canonical signaling is activated to induce HtrA1 in articular chondrocytes of the mouse models of OA.
Chondro--protective effect of the genetic inactivation of
A consensus of opinions in the OA research field is that mechanical stress is the primary initial insult to articular cartilage during the development of OA. Induction of TGF--β1 is one of the responses to mechanical stress in chondrocytes. Our studies demonstrated that normal mechanical loading of defective joints or an overloading of normal joints could stimulate chondrocytes to synthesize and release Tgf--β1 in mouse models of OA (15) . Based upon the data from our investigations and others' studies, we propose a molecular pathway (see the 
Conclusions
In summary, we believe that TGF--β1 is a pathogenic factor in the development of OA in adult joints. Therefore, inhibition of activity of TGF--β1, not application of TGF--β1, should be considered in the prevention and treatment of OA in the joints. Chondrocytes in wild--type littermates contains Tgfbr2, 100%. However, there were about less than 14% of chondrocytes with Tgfbr2 in the conditionally Tgfbr2 knockout mice. There were significant differences in the number of the Tgfbr2--cells between two groups, p<0.01 (t--test).
Figure 2. Morphology of articular cartilages in mouse knee joints
There were no overt morphological changes seen in the articular cartilages of knee joints in the Tgfbr2--deficient mice at the ages of 6 and 12 months.
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AgcCreERT2 +/--;Tgfbr2 +/+ AgcCreERT2 +/--;Tgfbr2 --/--12m Figure 3 . Immunohistostaining for collagen type X Collagen type X was present in the hypertrophic chondrocytes of growth plates in mice at the age of one month old. There were no positive staining of collagen type X in the articular cartilage of both tgfbr2--deficient mice and their wild--type littermates at the age of two months old.
Collagen X Growth plate (1 month)
AgcCreERT2 +/--;Tgfbr2 +/+ AgcCreERT2 +/--;Tgfbr2 --/-- Figure 4 . Lac--Z staining in the articular cartilage of temporomandibular (TM) joints in mice
There was an intensive Lac--Z staining in the articular cartilage of TM joints of AgcCreETt2/+,Rosa26floxlacZ/+ mice at the age of 1 and 6 months. 
